Complex diseases require complex therapies

EMBO Reports

Volumn 14, Issue 12, 2013, Pages 1039-1042

  Iyengar, Ravi ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EXENDIN 4; GLUCOSE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMATINIB; MUSCARINIC RECEPTOR BLOCKING AGENT; PAROXETINE; PENICILLIN DERIVATIVE; PRAVASTATIN; PROPRANOLOL; ROFECOXIB; ROSIGLITAZONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADVERSE DRUG REACTION; ANEURYSM; ARTICLE; ASTHMA; BACTERIAL CELL WALL; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOLOGY; DIABETES MELLITUS; DRUG BINDING; DRUG EFFICACY; DRUG TARGETING; FOOD AND DRUG ADMINISTRATION; GENOMICS; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERTENSION; IMMUNE COMPLEX DISEASE; KIDNEY DISEASE; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PEPTIC ULCER; PERSONALIZED MEDICINE; PHENOTYPE; PHYSICIAN; PRIORITY JOURNAL; SYSTEMS BIOLOGY; THERAPY; DRUG DEVELOPMENT; PROCEDURES; TRENDS;

DRUG DISCOVERY; SYSTEMS BIOLOGY; THERAPEUTICS;

EID: 84889098307     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2013.177     Document Type: Article

References (11)

1. Jordan JD, Landau EM, Iyengar R (2000) Signaling networks: The origins of cellular multitasking. Cell 103: 193-200
2. Ma'ayan A, Blitzer RD, Iyengar R (2005) Toward predictive models of mammalian cells. Annu Rev Biophys Biomol Struct 34: 319-349
3. Bhalla US, Iyengar R (1999) Emergent properties of networks of biological signaling pathways. Science 283: 381-387
4. Tanaka K, Augustine GJ (2008) A positive feedback signal transduction loop determines timing of cerebellar long-term depression. Neuron 59: 608-620
5. Yang Y et al (2011) Hunger states switch a flip-flop memory circuit via a synaptic AMPK-dependent positive feedback loop. Cell 146: 992-1003
6. Vidal M, Cusick ME, Barabási AL (2011) Interactome networks and human disease. Cell 144: 986-998
7. Tatonetti NP et al (2011) Detecting drug interactions from adverse-event reports: Interaction between paroxetine and pravastatin increases blood glucose levels. Clin Pharmacol Ther 90: 133-142
8. Thompson H (2013) Pipeline for COPD drugs flows with combination candidates. Nat Med 19: 1079
9. Kalos M et al (2011) T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med 3: 95ra73
10. Grady D (2012) In Girl's Last Hope, Altered Immune Cells Beat Leukemia. New York Times 9 Dec http://www.nytimes.com/2012/12/10/health/a-breakthrough- against-leukemia-using-altered-t-cells.html?-r=0
11. Zhao S et al (2013) Systems pharmacology of adverse event mitigation by drug combinations. Sci Transl Med 5: 206ra140